Anest. intenziv. Med. 2015;26(3):145-149

Anaesthetic management of the hypotonic uterusAnaesthesiology - Review articles

P. Nosková1,2,*, J. Bláha1,2, R. Klozová1,3, D. Seidlová1,4, P. Štourač1,5, A. Pařízek6
1 Sekce porodnické anestezie a analgezie ČSARIM
2 Klinika anesteziologie, resuscitace a intenzivni mediciny, 1. LF UK a VFN v Praze
3 Klinika anesteziologie a resuscitace, II. LF UK a FN Motol
4 II. anesteziologicko-resuscitační oddělení FN Brno
5 Klinika dětské anesteziologie a resuscitace, LF MU a FN Brno
6 Gynekologicko-porodnická klinika, 1. LF UK a VFN v Praze

Uterine hypotony/atony is the most common cause of life-threatening peripartum bleeding. The article presents information on the current treatment approaches for this serious complication. The pharmacological properties of the uterotonic agents are discussed in detail. Their incorrect administration may paradoxically lead to a deterioration in the critical condition. We also emphasize the need for concurrent interdisciplinary co-operation in the management of uterine hypotony/atony.

Keywords: uterine atony; uterotonic agents; intrauterine balloon tamponade; surgical interventions; hysterectomy

Received: January 18, 2015; Accepted: March 15, 2015; Published: June 1, 2015  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Nosková P, Bláha J, Klozová R, Seidlová D, Štourač P, Pařízek A. Anaesthetic management of the hypotonic uterus. Anest. intenziv. Med. 2015;26(3):145-149.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Kvasnička, J., Balík, M., Binder, T., Blatný, J., Bláha, J., Cvachovec, K., Černý, V., Dulíček, P., Feyereisl, J., Hájek, Z.,Janků, P., Malý, J., Měchurová, A., Pařízek, A., Penka, M., Procházka, M., Roztočil, A., Řeháček, V., Seidlová, D., Ševčík, P.,Valenta, J., Ventruba, P. Peripartální život ohrožující krvácení - mezioborové konsenzuální stanovisko. Vnitř. Lék., 2012, 58, 9, p. 661-664.
    2. Balík, M., Binder, T., Blatný, J., Bláha, J., Cvachovec, K., Černý, V., Dulíček, P., Feyereisl, J., Hájek, Z., Janků, P., Kvasnička, J., Malý, J., Měchurová, A., Pařízek, A., Penka, M., Procházka, M., Roztočil, A., Řeháček, V., Seidlová, D., Ševčík, P., Valenta, J., Ventruba P. Peripartální život ohrožující krvácení. Čes. Gynek., 2013, 78, Supplementum, p. 38-40.
    3. www.csarim.cz/Public/csim/PERIPARTALNI_ZIVOT_OHROZUJICI_KRVACENI_MEZIOBOROVE_KONSENSUALNI_STANOVISKO_2011.pdf
    4. Gard, J. W., Alexander, J. M., Bawdon, R. E., Albrecht, J. T. Oxytocin preparation stability in several common obstetric intravenous solutions. American Journal of Obstetrics and Gynecology, 2002, 186, 3, p. 496-498. Go to original source... Go to PubMed...
    5. Stephens, L. C., Bruessel, T. Systematic review of oxytocin dosing at caesarean section. Anaesthesia and intensive care, 2012, 40, 2, p. 247-252. Go to original source... Go to PubMed...
    6. Petersson, M. Cardiovascular effects of oxytocin. Progress in brain research, 2002, 139, p. 281-288. Go to original source... Go to PubMed...
    7. Gutkowska, J., Jankowski, M. Oxytocin revisited: its role in cardiovascular regulation. Journal of Neuroendocrinology, 2012, 24, 4, p. 599-608. Go to original source... Go to PubMed...
    8. Mukaddam-Daher, S., Yin, Y. L., Roy, J., Gutkowska, J., Cardinal, R. Negative inotropic and chronotropic effects of oxytocin. Hypertension, 2001, 38, 2, p. 292-296. Go to original source... Go to PubMed...
    9. Jonsson, M., Hanson, U., Lidell, C., Norden-Lindeberg, S. ST depression at caesarean section and the relation to oxytocin dose. A randomised controlled trial. BJOG : an international journal of obstetrics and gynaecology, 2010, 117, 1, p. 76-83. Go to original source... Go to PubMed...
    10. Svanstrom, M. C., Biber, B., Hanes, M., Johansson, G., Naslund, U., Balfors, E. M. Signs of myocardial ischaemia after injection of oxytocin: a randomized double-blind comparison of oxytocin and methylergometrine during Caesarean section. British Journal of Anaesthesia, 2008, 100, 5, p. 683-689. Go to original source... Go to PubMed...
    11. Archer, T. L., Knape, K., Liles, D., Wheeler, A. S., Carter, B. The hemodynamics of oxytocin and other vasoactive agents during neuraxial anesthesia for cesarean delivery: findings in six cases. International Journal of Obstetric Anesthesia, 2008, 17, 3, p. 247-254. Go to original source... Go to PubMed...
    12. Jackson, K. W., Jr., Allbert, J. R., Schemmer, G. K., Elliot, M., Humphrey, A., Taylor, J. A randomized controlled trial comparing oxytocin administration before and after placental delivery in the prevention of postpartum hemorrhage. American Journal of Obstetrics and Gynecology, 2001, 185, 4, p. 873-877. Go to original source... Go to PubMed...
    13. Davies, G. A., Tessier, J. L., Woodman, M. C., Lipson, A., Hahn, P. M. Maternal hemodynamics after oxytocin bolus compared with infusion in the third stage of labor: a randomized controlled trial. Obstetrics and Gynecology, 2005, 105, 2, p. 294-299. Go to original source... Go to PubMed...
    14. Nordstrom, L., Fogelstam, K., Fridman, G., Larsson, A., Rydhstroem, H. Routine oxytocin in the third stage of labour: a placebo controlled randomised trial. British Journal of Obstetrics and Gynaecology, 1997, 104, 7, p. 781-786. Go to original source... Go to PubMed...
    15. Thomas, J. S., Koh, S. H., Cooper, G. M. Haemodynamic effects of oxytocin given as i.v. bolus or infusion on women undergoing Caesarean section. British Journal of Anaesthesia, 2007, 98, 1, p. 116-119. Go to original source... Go to PubMed...
    16. Butwick, A. J., Coleman, L., Cohen, S. E., Riley, E. T., Carvalho, B. Minimum effective bolus dose of oxytocin during elective Caesarean delivery. British Journal of Anaesthesia, 2010, 104, 3, p. 338-343. Go to original source... Go to PubMed...
    17. Su, L. L., Chong, Y. S., Samuel, M. Carbetocin for preventing postpartum haemorrhage. Cochrane Database Syst. Rev., 2012, 4, CD005457. Go to original source... Go to PubMed...
    18. Dansereau, J., Joshi, A. K., Helewa, M. E., Doran, T. A., Lange, I. R., Luther, E. R., Farine, D., Schulz, M. L., Horbay, G. L., Griffin, P. et al. Double-blind comparison of carbetocin versus oxytocin in prevention of uterine atony after cesarean section. American Journal of Obstetrics and Gynecology, 1999, 180, 3 Pt, 1, p. 670-676. Go to original source... Go to PubMed...
    19. McDonald, S., Abbott, J. M., Higgins, S. P. Prophylactic ergometrine-oxytocin versus oxytocin for the third stage of labour. Cochrane Database Syst. Rev., 2004, 1, CD000201. Go to original source... Go to PubMed...
    20. Štourač, P., Bláha, J., Nosková, P., Klozová, R., Seidlová, D., Jarkovský, J., Zelinková, H. Časná poporodní anestezie z pohledu studie OBAAMA-CZ - prospektivní observační studie. Anest. intenziv. Med., 2014, 25, 5, p. 341-347.
    21. Stourac, P., Blaha, J., Klozova, R., Noskova, P., Seidlova, D., Brozova, L., Jarkovsky, J. Anesthesia for Cesarean Delivery in the Czech Republic: A 2011 National Survey. Anesth. Analg., 2014, Dec 16. [Epub ahead of print]. Go to PubMed...
    22. Larsen, R. Anestezie. Praha: Grada, 2004, p. 933.
    23. Larsen, R. Anestezie. Praha: Grada, 2004, p. 934.

    Return to the content


    Anesteziologie a intenzivní medicína

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.